All news from Anaesthesiology

PTSD: MDMA-assisted psychotherapy Benefits

When lasting trauma is caused by callous acts of violence, the key to recovery can be making meaning out of meaninglessness. Although such trauma is difficult to treat, the drug MDMA – known on the street as Ecstasy or Molly – appears to help when used as an adjunct to psychotherapy.

To Assess The Cost-Effectiveness Of Teledermoscopy For Skin Cancer Diagnosis

According to a study, researcher suspected that Teledermatology for skin cancer is slightly more expensive than usual care, but it expedites time to clinical resolution. The study was published in JAMA Dermatology.  The study using deidentified Australian health system data, store-and-forward teledermoscopy skin cancer referral was estimated to cost A$54.64 per person more than usual care but enabled clinical resolution to be achieved a mean of 26 days earlier.

Metabolic Profiles in Community-Acquired Pneumonia

In the current study, untargeted metabolomics research using liquid chromatography with tandem mass spectrometry (LC-MS/MS) was performed to identify CAP-related metabolic signatures. The identified metabolites were evaluated in the validation cohort by targeted assays. The relationship between the identified metabolites and the clinical severity of CAP as well as the determining performance for severe CAP were then investigated.

Niti Aayog to rework Ayushman Bharat

Niti Aayog has been asked to rework on the budgetary framework of Ayushman Bharat scheme, also known as the National Health Protection Scheme, after the Prime Minister’s Economic Advisory Council (PMEAC) pointed out that implementation cost of the project under the current model will go up by almost double than initial estimation.  The think tank has asked  Niti Aayog to come up  with more “realistic” budget for the project.

Afib Patients Are At A Risk Of Having Stroke

A new study found that integrating two separate clinical risk score models helps clinicians more accurately assess the stroke risk of patients with Afib. The composite stroke decision tool studied by researchers from the Intermountain Medical Center Heart Institute in Salt Lake City combines the widely used CHA2DS2-VASc with the Intermountain Risk Scores (IMRS) to derive and validate new stroke prediction scores.